Professional Documents
Culture Documents
DHARM A W ACANA
M E T R O
By
1. Adi Setiadji sukma
2. nurmala dewi
3. riana puspitasari
4. ridho wonargo
5. yudistiro fajar nugroho
6. sukma indriani
Breast cancer is a cancer that starts in the breast, usually in the inner lining of the milk
ducts or lobules. There are different types of breast cancer, with different stages
(spread), aggressiveness, and genetic makeup. Survival varies greatly depending on
those factors; with best treatment, 10-year disease-free survival varies from 98% to
10%. Treatment includes surgery, drugs (hormone therapy and chemotherapy), and
radiation
Management
The mainstay of breast cancer treatment is surgery. Adjuvant hormonal therapy (with
tamoxifen or an aromatase inhibitor) is given when the tumor expresses estrogen
receptors or progesterone receptors. Chemotherapy is given for more advanced stages of
disease. Monoclonal antibodies are sometimes used, especially for HER2-positive
tumors. Radiotherapy is given after surgery to the region of the tumor bed, to destroy
microscopic tumors that may have escaped surgery. Treatments are constantly being
evaluated in randomized, controlled trials, to evaluate and compare individual drugs,
combinations of drugs, and surgical and radiation techniques. The latest research is
reported annually at scientific meetings such as that of the American Society of Clinical
Oncology and St. Gallen, Switzerland.[citation needed] These studies are reviewed by
professional societies and other organizations, and formulated into guidelines for specific
treatment groups and risk category.
In planning treatment, doctors can also use PCR tests like Oncotype DX or microarray
tests that predict breast cancer recurrence risk based on gene expression. In February
2007, the first breast cancer predictor test won formal approval from the Food and Drug
Administration. This is a new gene test to help predict whether women with early-stage
breast cancer will relapse in 5 or 10 years, this could help influence how aggressively the
initial tumor is treated.[38]
Radiation therapy is also used to help destroy cancer cells that may linger after surgery.
Radiation therapy can be delivered as external beam radiotherapy or as brachytherapy
(internal radiotherapy). Radiation can reduce the risk of recurrence by 50-66% (1/2 2/3rds reduction of risk) when delivered in the correct dose.[39]
In 2008, the American College of Surgeons Oncology Group began a National Cancer
Institute funded study to explore the success of cryoablation therapy in the treatment of
Invasive Breast Carcinoma. The Visica 2TM Treatment System from Sanarus Technologies
was chosen as the exclusive cryoablation treatment technology for the study, which is
currently in Phase 2. [40]